13,30 Moreover, CCL2 has become reported to enhance osteoclastogenesis by inducing the expression of receptor activator of NF-κB (RANK) by osteoclast progenitors.31 RANK ligand (RANKL) more promotes the differentiation of osteoclast progenitors into purposeful osteoclasts, which could aggravate DP by producing alveolar bone resorption.32 These conclusions advise that CCL2 inhibition https://finnkyjwj.activablog.com/26560847/the-basic-principles-of-zongertinib